Stock CRVL CORVEL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials CorVel Corporation

Equities

CRVL

US2210061097

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
238.6 USD +0.22% Intraday chart for CorVel Corporation +1.83% -3.47%
Mar. 25 Canadian firm launches AI-powered ETF targeting AI investments RE
Feb. 26 Corvel Insider Sold Shares Worth $793,205, According to a Recent SEC Filing MT

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 954.4 1,216 986.9 1,834 2,968 3,265
Enterprise Value (EV) 1 898.6 1,124 1,002 1,749 2,914 3,227
P/E ratio 27 x 26.5 x 21.4 x 40.2 x 46 x 50.5 x
Yield - - - - - -
Capitalization / Revenue 1.71 x 2.04 x 1.67 x 3.32 x 4.59 x 4.54 x
EV / Revenue 1.61 x 1.89 x 1.69 x 3.16 x 4.51 x 4.49 x
EV / EBITDA 12.9 x 13.3 x 12 x 21.2 x 26.9 x 29.4 x
EV / FCF 32.3 x 21.1 x 29.3 x 23.7 x 131 x 61.8 x
FCF Yield 3.1% 4.73% 3.41% 4.23% 0.76% 1.62%
Price to Book 5.59 x 6.21 x 5.16 x 8.32 x 13.9 x 16.2 x
Nbr of stocks (in thousands) 18,880 18,638 18,105 17,877 17,621 17,159
Reference price 2 50.55 65.24 54.51 102.6 168.4 190.3
Announcement Date 6/8/18 6/7/19 6/10/20 5/28/21 5/27/22 5/26/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 558.4 595.7 592.2 552.6 646.2 718.6
EBITDA 1 69.68 84.5 83.23 82.61 108.4 109.7
EBIT 1 47.9 61.51 60.71 59.18 84.51 84.55
Operating Margin 8.58% 10.33% 10.25% 10.71% 13.08% 11.77%
Earnings before Tax (EBT) 1 47.9 61.51 60.71 59.18 84.51 84.55
Net income 1 35.7 46.7 47.38 46.36 66.41 66.36
Net margin 6.39% 7.84% 8% 8.39% 10.28% 9.24%
EPS 2 1.870 2.460 2.550 2.550 3.660 3.770
Free Cash Flow 1 27.84 53.2 34.14 73.93 22.18 52.22
FCF margin 4.99% 8.93% 5.77% 13.38% 3.43% 7.27%
FCF Conversion (EBITDA) 39.95% 62.96% 41.03% 89.49% 20.45% 47.61%
FCF Conversion (Net income) 77.99% 113.91% 72.07% 159.48% 33.39% 78.69%
Dividend per Share - - - - - -
Announcement Date 6/8/18 6/7/19 6/10/20 5/28/21 5/27/22 5/26/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 15.1 - - -
Net Cash position 1 55.8 91.7 - 85.1 54.4 37.6
Leverage (Debt/EBITDA) - - 0.1814 x - - -
Free Cash Flow 1 27.8 53.2 34.1 73.9 22.2 52.2
ROE (net income / shareholders' equity) 23% 25.5% 24.6% 22.6% 30.7% 32%
ROA (Net income/ Total Assets) 11.8% 13% 10.3% 8.8% 12.6% 13.1%
Assets 1 303.7 359.6 458.4 527.1 528.1 508.1
Book Value Per Share 2 9.050 10.50 10.60 12.30 12.10 11.80
Cash Flow per Share 2 2.950 4.940 4.630 7.820 5.550 4.150
Capex 1 27.7 15.3 32.4 17.2 29.8 26.3
Capex / Sales 4.96% 2.56% 5.46% 3.12% 4.61% 3.66%
Announcement Date 6/8/18 6/7/19 6/10/20 5/28/21 5/27/22 5/26/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CORVEL CORPORATION Stock CorVel Corporation
-3.47% 4.08B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. CRVL Stock
  4. Financials CorVel Corporation